144 related articles for article (PubMed ID: 10397943)
1. Crystallization of beta-estradiol in an acrylic transdermal drug delivery system.
Variankaval NE; Jacob KI; Dinh SM
J Biomed Mater Res; 1999 Mar; 44(4):397-406. PubMed ID: 10397943
[TBL] [Abstract][Full Text] [Related]
2. Effect of adhesive layer thickness and drug loading on estradiol crystallization in a transdermal drug delivery system.
Imani M; Lahooti-Fard F; Taghizadeh SM; Takrousta M
AAPS PharmSciTech; 2010 Sep; 11(3):1268-75. PubMed ID: 20706877
[TBL] [Abstract][Full Text] [Related]
3. Eudragits: role as crystallization inhibitors in drug-in-adhesive transdermal systems of estradiol.
Kotiyan PN; Vavia PR
Eur J Pharm Biopharm; 2001 Sep; 52(2):173-80. PubMed ID: 11522483
[TBL] [Abstract][Full Text] [Related]
4. Crystallisation of estradiol containing TDDS determined by isothermal microcalorimetry, X-ray diffraction, and optical microscopy.
Latsch S; Selzer T; Fink L; Kreuter J
Eur J Pharm Biopharm; 2003 Jul; 56(1):43-52. PubMed ID: 12837480
[TBL] [Abstract][Full Text] [Related]
5. Use of X-ray crystallography for the characterization of single crystals grown in steroid containing transdermal drug delivery systems.
Lipp R; Müller-Fahrnow A
Eur J Pharm Biopharm; 1999 Mar; 47(2):133-8. PubMed ID: 10234537
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of 17-beta estradiol in a transdermal drug delivery system.
Variankaval NE; Jacob KI; Dinh SM
J Mater Sci Mater Med; 2002 Mar; 13(3):271-80. PubMed ID: 15348624
[TBL] [Abstract][Full Text] [Related]
7. Sustainable UV-Crosslinkable Acrylic Pressure-Sensitive Adhesives for Medical Application.
Ossowicz-Rupniewska P; Bednarczyk P; Nowak M; Nowak A; Duchnik W; Kucharski Ł; Rokicka J; Klimowicz A; Czech Z
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769271
[TBL] [Abstract][Full Text] [Related]
8. Use of isothermal heat conduction microcalorimetry, X-ray diffraction, and optical microscopy for characterisation of crystals grown in steroid combination-containing transdermal drug delivery systems.
Latsch S; Selzer T; Fink L; Horstmann M; Kreuter J
Eur J Pharm Biopharm; 2004 Mar; 57(2):397-410. PubMed ID: 15019001
[TBL] [Abstract][Full Text] [Related]
9. Drug release and adhesive properties of crospovidone-containing matrix patches based on polyisobutene and acrylic adhesives.
Schulz M; Fussnegger B; Bodmeier R
Eur J Pharm Sci; 2010 Dec; 41(5):675-84. PubMed ID: 20883778
[TBL] [Abstract][Full Text] [Related]
10. Acrylic resins as rate-controlling membranes in novel formulation of a nine-day 17beta-estradiol transdermal delivery system: in vitro and release modifier effect evaluation.
Rafiee-Tehrani M; Safaii-Nikui N; Peteriet H; Beckert T
Drug Dev Ind Pharm; 2001 May; 27(5):431-7. PubMed ID: 11448050
[TBL] [Abstract][Full Text] [Related]
11. Drug recrystallization in drug-in-adhesive transdermal delivery system: A case study of deteriorating the mechanical and rheological characteristics of testosterone TDS.
Mohamed LA; Kamal N; Elfakhri KH; Willett D; Wokovich A; Strasinger C; Cruz CN; Raney SG; Ashraf M; Zidan AS
Int J Pharm; 2020 Mar; 578():119132. PubMed ID: 32057892
[TBL] [Abstract][Full Text] [Related]
12. Development and in vitro evaluation of pressure sensitive adhesive patch for the transdermal delivery of galantamine: Effect of penetration enhancers and crystallization inhibition.
Ameen D; Michniak-Kohn B
Eur J Pharm Biopharm; 2019 Jun; 139():262-271. PubMed ID: 30981946
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of ion-pair releasing from acrylic pressure sensitive adhesive containing carboxyl group: Roles of doubly ionic hydrogen bond in the controlled release process of bisoprolol ion-pair.
Zhao H; Liu C; Yang D; Wan X; Shang R; Quan P; Fang L
J Control Release; 2018 Nov; 289():146-157. PubMed ID: 30268589
[TBL] [Abstract][Full Text] [Related]
14. Solvent effects on physicochemical behavior of estradiols recrystallized for transdermal delivery.
Park JS; Park YJ; Kang HW; Kim CK
Arch Pharm Res; 2008 Jan; 31(1):111-6. PubMed ID: 18277616
[TBL] [Abstract][Full Text] [Related]
15. Formulation optimization of a drug in adhesive transdermal analgesic patch.
Ravula R; Herwadkar AK; Abla MJ; Little J; Banga AK
Drug Dev Ind Pharm; 2016; 42(6):862-70. PubMed ID: 26288995
[TBL] [Abstract][Full Text] [Related]
16. Development of a Predictive Model for the Long-Term Stability Assessment of Drug-In-Adhesive Transdermal Films Using Polar Pressure-Sensitive Adhesives as Carrier/Matrix.
Chenevas-Paule C; Wolff HM; Ashton M; Schubert M; Dodou K
J Pharm Sci; 2017 May; 106(5):1293-1301. PubMed ID: 28088456
[TBL] [Abstract][Full Text] [Related]
17. Mussel-inspired poly(hydroxyethyl acrylate-co-itaconic acid)-catechol/hyaluronic acid drug-in-adhesive patches for transdermal delivery of ketoprofen.
Arunprasert K; Pornpitchanarong C; Rojanarata T; Ngawhirunpat T; Opanasopit P; Patrojanasophon P
Int J Pharm; 2022 Dec; 629():122362. PubMed ID: 36379396
[TBL] [Abstract][Full Text] [Related]
18. Silicone adhesive, a better matrix for tolterodine patches-a research based on in vitro/in vivo studies.
Liu J; Wang Z; Liu C; Xi H; Li C; Chen Y; Sun L; Mu L; Fang L
Drug Dev Ind Pharm; 2012 Aug; 38(8):1008-14. PubMed ID: 22126709
[TBL] [Abstract][Full Text] [Related]
19. Probing the role of chemical enhancers in facilitating drug release from patches: Mechanistic insights based on FT-IR spectroscopy, molecular modeling and thermal analysis.
Song W; Quan P; Li S; Liu C; Lv S; Zhao Y; Fang L
J Control Release; 2016 Apr; 227():13-22. PubMed ID: 26896738
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of crystallization in drug-in-adhesive-type transdermal patches.
Jain P; Banga AK
Int J Pharm; 2010 Jul; 394(1-2):68-74. PubMed ID: 20438819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
